RESPONSIVENESS OF VERY LOW-DOSE WARFARIN ASSOCIATED WITH GENETIC VARIANTS OF VKORC1, CYP2C9, CYP4F2 AND CYP2C19 IN INDONESIAN PATIENTS.

被引：0
|
作者：
Rusdiana, T. [1 ]
Araki, T. [1 ]
Nakamura, T. [1 ]
Subarnas, A. [2 ]
Yamamoto, K. [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Clin Pharmacol, Maebashi, Gunma 371, Japan
[2] Padjadjaran State Univ, Fac Pharm, Bandung, Indonesia
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [1] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    Rusdiana, T.
    Araki, T.
    Nakamura, T.
    Subarnas, A.
    Yamamoto, K.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 395 - 405
  • [2] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    T. Rusdiana
    T. Araki
    T. Nakamura
    A. Subarnas
    K. Yamamoto
    [J]. European Journal of Clinical Pharmacology, 2013, 69 : 395 - 405
  • [3] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    [J]. BLOOD, 2012, 120 (21)
  • [4] Study of VKORC1, CYP2C9, and CYP4F2 polymorphisms and their association with warfarin dose requirements in Egyptian patients.
    Shahin, Mohamed H.
    Khalifa, Sherief I.
    Sallam, Tarif H.
    Hammad, Lamiaa N.
    El Shafey, Mostafa
    Ali, Shawky S.
    Mohamed, Mohamed-Eslam F.
    Langaee, Taimour
    Johnson, Julie A.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1065 - 1065
  • [5] Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population
    Ozer, Mahmut
    Demirci, Yeliz
    Hizel, Candan
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Alpan, Serdar
    Genc, Ece
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (03) : 209 - 214
  • [6] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Kocael, Ahmet
    Eronat, Allison Pinar
    Tuzuner, Mete Bora
    Ekmekci, Ahmet
    Orhan, Ahmet Lutfullah
    Ikizceli, Ibrahim
    Yilmaz-Aydogan, Hulya
    Ozturk, Oguz
    [J]. MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) : 1825 - 1833
  • [7] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Ahmet Kocael
    Allison Pınar Eronat
    Mete Bora Tüzüner
    Ahmet Ekmekçi
    Ahmet Lütfullah Orhan
    İbrahim İkizceli
    Hülya Yılmaz-Aydoğan
    Oğuz Öztürk
    [J]. Molecular Biology Reports, 2019, 46 : 1825 - 1833
  • [8] The effect of polymorphisms in CYP2C9, CYP4F2, EPHX1 and VKORC1 on warfarin dose in Turkish patients
    Ozer, Mahmut
    Demirci, Yeliz
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Hizel, Candan
    Alpan, Serdar
    Genc, Ece
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S125 - S125
  • [9] A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 640 - 648
  • [10] PHARMACOGENOMIC VARIANTS OF CYP2C9, CYP4F2 AND VKORC1 AND ITS RELATION TO WARFARIN RESPONSE IN NATIVE OMANI PATIENTS
    Pathare, A.
    AlZadjali, S.
    Misquith, R.
    Gravell, D.
    Al Falahi, K.
    Al-Haddabi, H.
    Krishnamoorthy, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 668 - 668
12345